Home |
Free Dividend Report |
Stock Splits Calendar |
XBIO Stock Split History |
Preferred Stock Newsletter |
XBIO Options Chain |
Stock Message Boards |
Xenetic Biosciences (XBIO) has 2 splits in our XBIO split history database. The first split for XBIO took place on June 25, 2019. This was a 1 for 12 reverse split, meaning for each 12 shares of XBIO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split. XBIO's second split took place on May 15, 2023. This was a 1 for 10 reverse split, meaning for each 10 shares of XBIO owned pre-split, the shareholder now owned 1 share. For example, a 83.3333333333333 share position pre-split, became a 8.33333333333333 share position following the split.
When a company such as Xenetic Biosciences conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the XBIO split history from start to finish, an original position size of 1000 shares would have turned into 8.33333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xenetic Biosciences shares, starting with a $10,000 purchase of XBIO, presented on a split-history-adjusted basis factoring in the complete XBIO split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 06/30/2016 | |
End date: | 03/28/2024 | |
Start price/share: | $612.00 | |
End price/share: | $3.77 | |
Dividends collected/share: | $0.00 | |
Total return: | -99.38% | |
Average Annual Total Return: | -48.15% | |
Starting investment: | $10,000.00 | |
Ending investment: | $61.64 | |
Years: | 7.75 |
About Xenetic Biosciences |
Xenetic Biosciences is a biopharmaceutical company. Co.'s drug candidates pipeline include: XCART, which is a CAR T cell platform technology engineered to target patient-specific tumor neoantigens; ErepoXen (polysialylated erythropoietin), which uses Co.'s PolyXen platform technology for the treatment of anemia in chronic kidney disease patients; XBIO-101, which is an internal candidate with orphan drug designation from the U.S. Food and Drug Administration for the potential treatment of progesterone receptor negative endometrial cancer in conjunction with progesterone therapy; and OncoHist, which utilizes the properties of modified human histone H1.3 for targeted cell killing. According to our XBIO split history records, Xenetic Biosciences has had 2 splits. |
XBIO Split History Table | |
Date | Ratio |
06/25/2019 | 1 for 12 |
05/15/2023 | 1 for 10 |
Healthcare Stock Splits |
XBIO is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
XOMA Split History Also explore: XBIO shares outstanding history
Free XBIO Email Alerts:
|
XBIO Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.